TRIIODOTHYRONINE RESUSCITATES THE IMPAIRED LIVER-FUNCTION AFTER PRINGLES MANEUVER

被引:0
|
作者
OKAMOTO, S
NAGAMATSU, K
TOKUKA, A
MANAKA, D
TANAKA, A
SHIMABUKURO, T
UEDA, M
YAMAOKA, Y
机构
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate the changes in thyroid hormone levels and the effectiveness of exogenous triiodothyronine (T-3) in shock caused by prolonged use of Pringle's maneuver (cross-clamping of hepatic triads). Design: Pringle's maneuver was performed on dogs for 1 hour. In the T-3 group (n=7), 1 mu g/kg per hour of T-3 was administered intravenously for 3 hours after declamping. In the control group (n=7), the same volume of saline solution without T-3 was administered. Main Outcome Measures: Serum T-3, reverse T-3, thyroxine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and the ketone body-ratio (AKBR), which reflect the hepatic energy charge, were measured. Tissue blood flow, tissue blood velocity, and tissue blood mass of the liver were measured by means of a laser Doppler flowmeter. Oxygen saturation of the hemoglobin in the liver tissue was measured by tissue near-infrared spectroscopy. Dogs were observed until the seventh postoperative day. Results: In the control group, the low T-3 syndrome was observed. None of the dogs recovered from the shock and none survived for more than 24 hours. In the T-3 group, all dogs recovered from the shock and survived. In the control group, hepatic tissue blood flow and oxygen saturation of hemoglobin in liver tissue were decreased, and the AKBR was deteriorated. In the T-3 group, however, these parameters were markedly improved. Conclusion: It is suggested that T-3 administration is beneficial in managing the critical resuscitation period of liver function after Pringle's maneuver is performed in dogs.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF CIPROFLOXACIN IN IMPAIRED LIVER-FUNCTION
    ESPOSITO, S
    MINIERO, M
    BARBA, D
    SAGNELLI, E
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1989, 9 (01) : 37 - 41
  • [2] PHARMACOKINETICS OF GUANABENZ IN PATIENTS WITH IMPAIRED LIVER-FUNCTION
    LASSETER, KC
    SHAPSE, D
    PASCUCCI, VL
    CHIANG, ST
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 : S766 - S770
  • [3] PARENTERAL FEEDING IN CASES OF IMPAIRED LIVER-FUNCTION
    STRIEBEL, JP
    LUTZ, H
    PRAKTISCHE ANASTHESIE WIEDERBELEBUNG UND INTENSIVTHERAPIE, 1977, 12 (01): : 20 - 30
  • [4] MITOCHONDRIAL INJURY AND IMPAIRED LIVER-FUNCTION IN AFLATOXIN TOXICITY
    RAJ, HG
    VENKITAS.TA
    ZEITSCHRIFT FUR LEBENSMITTEL-UNTERSUCHUNG UND-FORSCHUNG, 1974, 154 (04): : 201 - 205
  • [5] THE PHARMACOKINETICS OF CASODEX ENANTIOMERS IN SUBJECTS WITH IMPAIRED LIVER-FUNCTION
    COCKSHOTT, ID
    SOTANIEMI, EA
    COOPER, KJ
    JONES, DC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (04) : 339 - 343
  • [6] THE EFFECTS OF IMPAIRED LIVER-FUNCTION ON THE ELIMINATION OF ANTINEOPLASTIC AGENTS
    KOREN, G
    BEATTY, K
    SETO, A
    EINARSON, TR
    LISHNER, M
    ANNALS OF PHARMACOTHERAPY, 1992, 26 (03) : 363 - 371
  • [7] INFLUENCE OF IMPAIRED LIVER-FUNCTION UPON PHARMACOKINETICS OF CEFIXIME
    SINGLAS, E
    LEBREC, D
    GAUDIN, C
    MONTAY, G
    ROCHE, G
    TABURET, AM
    PRESSE MEDICALE, 1989, 18 (32): : 1587 - 1588
  • [8] LIVER-FUNCTION AFTER ALTHESIN INFUSION
    HENDERSON, JJ
    ANAESTHESIA, 1982, 37 (01) : 85 - 86
  • [9] IMPAIRED KIDNEY-FUNCTION IN CIRRHOTIC-PATIENTS DOES NOT CORRELATE WITH IMPAIRED LIVER-FUNCTION
    HOFFMANN, K
    HEIDEMANN, HT
    OHNHAUS, EE
    JOURNAL OF HEPATOLOGY, 1987, 5 : S145 - S145
  • [10] IMPAIRED LIVER-FUNCTION IN STABLE RENAL-ALLOGRAFT RECIPIENTS
    FREY, FJ
    SCHAAD, HJ
    RENNER, EL
    HORBER, FF
    FREY, BM
    PREISIG, R
    HEPATOLOGY, 1989, 9 (04) : 606 - 613